Sanofi delivers Business EPS growth of 10.3% at CER in Q3 2014
Third quarter results 2014 were reviewed by management during a conference call. The presentation was followed by a Q&A session.
Third quarter results 2014 were reviewed by management during a conference call. The presentation was followed by a Q&A session.